<?xml version="1.0" encoding="UTF-8"?>
<collection xmlns="http://www.loc.gov/MARC21/slim">
 <record>
  <leader>     caa a22        4500</leader>
  <controlfield tag="001">445326433</controlfield>
  <controlfield tag="003">CHVBK</controlfield>
  <controlfield tag="005">20180317142722.0</controlfield>
  <controlfield tag="007">cr unu---uuuuu</controlfield>
  <controlfield tag="008">170323e20110901xx      s     000 0 eng  </controlfield>
  <datafield tag="024" ind1="7" ind2="0">
   <subfield code="a">10.1007/s10989-011-9253-0</subfield>
   <subfield code="2">doi</subfield>
  </datafield>
  <datafield tag="035" ind1=" " ind2=" ">
   <subfield code="a">(NATIONALLICENCE)springer-10.1007/s10989-011-9253-0</subfield>
  </datafield>
  <datafield tag="245" ind1="0" ind2="0">
   <subfield code="a">Two Novel Anticancer Peptides from Aurein1.2</subfield>
   <subfield code="h">[Elektronische Daten]</subfield>
   <subfield code="c">[Shahrbanoo Karbalaeemohammad, Hossein Naderi-Manesh]</subfield>
  </datafield>
  <datafield tag="520" ind1="3" ind2=" ">
   <subfield code="a">Aurein1.2 is a cationic peptide with antimicrobial and anticancer activity. In order to find a novel peptide with this activity, aurein1.2 was utilized as a template and the sequences were designed by a RosettaDesign server with our proposed pattern. As a result, tempY was designed and synthesized, and its structural and biological activity was investigated. TempY has a sequence similar to that of the temporins group but with potent antibacterial properties against Gram-positive bacteria and effective anticancer activity (LC50 is 20-30μg/ml). This latter activity may be due to the tyrosine at the C terminus of the peptide. Kar peptide is another model derived from the complete design of aurein1.2. Kar is only active against A549 cells. The net charge of Kar is four, and it is inactive against Gram-positive bacteria and MCF-7 cells, which may be due to the high positive-charge density on the surface of peptide.</subfield>
  </datafield>
  <datafield tag="540" ind1=" " ind2=" ">
   <subfield code="a">Springer Science+Business Media, LLC, 2011</subfield>
  </datafield>
  <datafield tag="690" ind1=" " ind2="7">
   <subfield code="a">Anticancer activity</subfield>
   <subfield code="2">nationallicence</subfield>
  </datafield>
  <datafield tag="690" ind1=" " ind2="7">
   <subfield code="a">Peptide</subfield>
   <subfield code="2">nationallicence</subfield>
  </datafield>
  <datafield tag="690" ind1=" " ind2="7">
   <subfield code="a">Temporin</subfield>
   <subfield code="2">nationallicence</subfield>
  </datafield>
  <datafield tag="690" ind1=" " ind2="7">
   <subfield code="a">Aurein1.2</subfield>
   <subfield code="2">nationallicence</subfield>
  </datafield>
  <datafield tag="690" ind1=" " ind2="7">
   <subfield code="a">Antimicrobial activity</subfield>
   <subfield code="2">nationallicence</subfield>
  </datafield>
  <datafield tag="700" ind1="1" ind2=" ">
   <subfield code="a">Karbalaeemohammad</subfield>
   <subfield code="D">Shahrbanoo</subfield>
   <subfield code="u">Department of Biophysics &amp; Biochemistry, Tarbiat Modares University, Tehran, Iran</subfield>
   <subfield code="4">aut</subfield>
  </datafield>
  <datafield tag="700" ind1="1" ind2=" ">
   <subfield code="a">Naderi-Manesh</subfield>
   <subfield code="D">Hossein</subfield>
   <subfield code="u">Department of Biophysics &amp; Biochemistry, Tarbiat Modares University, Tehran, Iran</subfield>
   <subfield code="4">aut</subfield>
  </datafield>
  <datafield tag="773" ind1="0" ind2=" ">
   <subfield code="t">International Journal of Peptide Research and Therapeutics</subfield>
   <subfield code="d">Springer Netherlands</subfield>
   <subfield code="g">17/3(2011-09-01), 159-164</subfield>
   <subfield code="x">1573-3149</subfield>
   <subfield code="q">17:3&lt;159</subfield>
   <subfield code="1">2011</subfield>
   <subfield code="2">17</subfield>
   <subfield code="o">10989</subfield>
  </datafield>
  <datafield tag="856" ind1="4" ind2="0">
   <subfield code="u">https://doi.org/10.1007/s10989-011-9253-0</subfield>
   <subfield code="q">text/html</subfield>
   <subfield code="z">Onlinezugriff via DOI</subfield>
  </datafield>
  <datafield tag="908" ind1=" " ind2=" ">
   <subfield code="D">1</subfield>
   <subfield code="a">research-article</subfield>
   <subfield code="2">jats</subfield>
  </datafield>
  <datafield tag="950" ind1=" " ind2=" ">
   <subfield code="B">NATIONALLICENCE</subfield>
   <subfield code="P">856</subfield>
   <subfield code="E">40</subfield>
   <subfield code="u">https://doi.org/10.1007/s10989-011-9253-0</subfield>
   <subfield code="q">text/html</subfield>
   <subfield code="z">Onlinezugriff via DOI</subfield>
  </datafield>
  <datafield tag="950" ind1=" " ind2=" ">
   <subfield code="B">NATIONALLICENCE</subfield>
   <subfield code="P">700</subfield>
   <subfield code="E">1-</subfield>
   <subfield code="a">Karbalaeemohammad</subfield>
   <subfield code="D">Shahrbanoo</subfield>
   <subfield code="u">Department of Biophysics &amp; Biochemistry, Tarbiat Modares University, Tehran, Iran</subfield>
   <subfield code="4">aut</subfield>
  </datafield>
  <datafield tag="950" ind1=" " ind2=" ">
   <subfield code="B">NATIONALLICENCE</subfield>
   <subfield code="P">700</subfield>
   <subfield code="E">1-</subfield>
   <subfield code="a">Naderi-Manesh</subfield>
   <subfield code="D">Hossein</subfield>
   <subfield code="u">Department of Biophysics &amp; Biochemistry, Tarbiat Modares University, Tehran, Iran</subfield>
   <subfield code="4">aut</subfield>
  </datafield>
  <datafield tag="950" ind1=" " ind2=" ">
   <subfield code="B">NATIONALLICENCE</subfield>
   <subfield code="P">773</subfield>
   <subfield code="E">0-</subfield>
   <subfield code="t">International Journal of Peptide Research and Therapeutics</subfield>
   <subfield code="d">Springer Netherlands</subfield>
   <subfield code="g">17/3(2011-09-01), 159-164</subfield>
   <subfield code="x">1573-3149</subfield>
   <subfield code="q">17:3&lt;159</subfield>
   <subfield code="1">2011</subfield>
   <subfield code="2">17</subfield>
   <subfield code="o">10989</subfield>
  </datafield>
  <datafield tag="900" ind1=" " ind2="7">
   <subfield code="a">Metadata rights reserved</subfield>
   <subfield code="b">Springer special CC-BY-NC licence</subfield>
   <subfield code="2">nationallicence</subfield>
  </datafield>
  <datafield tag="898" ind1=" " ind2=" ">
   <subfield code="a">BK010053</subfield>
   <subfield code="b">XK010053</subfield>
   <subfield code="c">XK010000</subfield>
  </datafield>
  <datafield tag="949" ind1=" " ind2=" ">
   <subfield code="B">NATIONALLICENCE</subfield>
   <subfield code="F">NATIONALLICENCE</subfield>
   <subfield code="b">NL-springer</subfield>
  </datafield>
 </record>
</collection>
